LuisERaezMDFACP FCCP

Oncology • Pembroke Pines, FL

Medical Director, Memorial Cancer Institute (MCI), Memorial Health Care System, Florida

Join to view full profile

Dr. Raez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raez's full profile

Already have an account?

Office
801 N Flamingo Rd
Suite 11
Pembroke Pines, FL 33028
Phone+1 954-844-6868

Fax+1 954-443-4747

Summary

Luis E. Raez, MD, FACP, FCCP; is the Medical Director & Chief Scientific Officer of Memorial Cancer Institute at Memorial Health Care System in Florida and Director of the Thoracic Oncology Program. He was President of the Florida Society of Clinical Ocnology (FLASCO) from 2019-2021. He is also Clinical Professor of Medicine at Florida International University (FIU), Clinical Research Professor at Florida Atlantic University (FAU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru.
He was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer.
He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research in the areas of cancer vaccines. He has been funded by NCI and the pharma industry. He has given oral presentations and lectures in national and international meetings in the US, Europe, Latinamerica and Asia.
He is American Board Certified in: Internal Medicine, Medical Oncology. He is Board Elegible in Hematology.
He is a member of AACR, ESMO, ASCO, IASLAC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, FLASCO among other institutions.

Education & Training

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1999
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1993 - 1996
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1993 - 1994
Cayetano Heredia UniversityClass of 1990
University of Miami

Certifications & Licensure

FL State Medical License 1996 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Listed in Who’s Who among Executives and Professionals Throughout the World 2009-Present, 2012
Listed in Cambridge Who’s who 2007-present, 2012
Listed in Marquis Who's Who in the World 2006-Present, 2012
Listed in Marquis Who's Who in Science and Engineering 2005-present, 2012
Listed in Outstanding Intellectuals of the 20th Century 2003 - present, 2012
Listed in Stratton’s Who is Who in America 2002-Present, 2012
Listed in Marquis Who's Who in America 2001-Present, 2012
Listed in Marquis "Who's Who in Medicine and Health Care" in America 2001-present, 2012
Honorary Member Sociedad Peruana de Oncologia Medica (SPOM), 2011
Promoted to: Master in the American College of Specialists in Geriatrics (MACSG) 2010
Listed as one of The Best Doctors in America 2005-6, 2009, 2010
University of Miami/Sylvester Comprehensive Cancer Center Intramural Grant Award 2008
Promoted to the Fellowship in the American College of Specialists in Geriatrics 2008
Elected for the Fellowship American College of Chest Physicians, 2007
James and Esther King Award 2005-2007, 2007
Clinical Innovator Award The Flight Attendant Research Institute, 2005-2006, 2006
Listed in the Guide to America’s Top Physicians 2005, 2006
Second place Sylvester Comprehensive Cancer Center/University of Miami: Annual Research Poster Sessions, 1999, 2005
Papanicolaou Corps Distinguished Investigator of the year 2005
Women's Cancer Association (WCA) Award 2003
Fellow (FACP) American College of Physicians, 2002
Stanley J. Glaser Foundation Biomedical Research Award 2002-2003, 2002
Research Career Development Award Society of Clinical Oncology (ASCO), 2002
Promoted to the Fellowship in the American College of Physicians (ACP) Sylvester Comprehensive Cancer Center/University of Miami: Annual Research Poster Sessions, 2002
Third place Sylvester Comprehensive Cancer Center/University of Miami: Annual Research Poster Sessions, 2001
Physicians' Recognition Award in Continuing Medical Education by American Medical Association (AMA), 1998, 1999, 2000, 2001
First place Sylvester Comprehensive Cancer Center/University of Miami: Annual Research Poster Sessions, 1998
Outstanding Resident of the Year American College of Physicians (ACP), Florida Chapter, 1995, 1996
Third Place in Research Poster Presentations X Chilean Congress of Infectious Diseases, Vina del Mar, Chile, 1993
Highest GPA during 1991-1992 Internship Cayetano Heredia Peruvian University, 1991, 1992
Ranked in the top 10% in the 1992 graduating class Cayetano Heredia Peruvian University, 1992
Award of Collaboration and Dedication to Student Affairs and University Welfare Cayetano Heredia Peruvian University, 1989
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) Start of enrollment: 2004 Apr 01
Completed
Phase 1
Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors Start of enrollment: 2004 Feb 01
Completed
Phase 1
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Jun 01
Completed
Phase 2
Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Start of enrollment: 2004 Feb 01
Completed
Phase 2
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer Start of enrollment: 2004 Jan 01
Completed
Phase 2
Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy Start of enrollment: 2007 May 01
Completed
Phase 1
Vaccine Therapy in Patients With Stages IIIB/IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy Start of enrollment: 2009 Jan 01
Terminated
Phase 1, Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network Start of enrollment: 2010 Nov 01
Terminated
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
MEK162 for Patients With RAS/RAF/MEK Activated Tumors Start of enrollment: 2013 Oct 10
Completed
Phase 2
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation Start of enrollment: 2022 Oct 20
Recruiting
Phase 1
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over t...
Luis E Raez, Ashish C Massey, Scott S Barker, Patrick M Peterson, Katherine Liming
The Oncologist. 2024-12-06
1 citations
Genomic ancestry and cancer among Latin Americans.
Alejandro Ruíz-Patiño, Leonardo Rojas, Jairo Zuluaga, Oscar Arrieta, Luis Corrales
Clinical & Translational Oncology. 2024-08-01
1 citations
Real-world clinical and economic outcomes for patients with advanced non-small cell lung cancer enrolled in a clinical trial following comprehensive genomic profiling ...
Julie A Wiedower, Shaun P Forbes, L Jill Tsai, Jiemin Liao, Luis E Raez
Journal of Managed Care & Specialty Pharmacy. 2024-07-01

Journal Articles

Phase 2 study of bortezomib alone and in combination with docetaxel in advanced non-small cell lung cancer.
Fanucchi MP, Fossella F, Belt F, Natale R, Fidias P, Carbone D, Govindan R, Raez LE, Robert F, Ribeiro M, Axelrod R, Kashala O, Sheng S, Schiller J, J Clin Oncol; 24(31):5025-33
Stem cell research and the human embrion.
Raez LE, Revista VE; 17 (50): 87-105
Epidermal growth factor vaccine in non-small-cell lung cancer.
Gonzalez Marinello GM, Santos ES, Raez LE, Expert Rev Anticancer Ther;12(4):439-45
Targeting the Met pathway in lung cancer.
Belalcazar A, Azaña D, Perez CA, Raez LE, Santos ES, Expert Rev Anticancer Ther; 12(4):519-28
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Perez CA, Song H, Raez LE, Agulnik M, Grushko TA, Dekker A, Stenson K, Blair EA, Olopade OI, Seiwert TY, Vokes EE, Cohen EE, Oral Oncol
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Rocha-Lima CM, Bayraktar S, Macintyre J, Raez LE, Flores AM, Ferrell A, Rubin EH, Poplin EA, Tan AR, Lucarelli A, Zojwalla N, Cancer. doi: 10.1002/cncr.27428.
The dilemma between accelerated second line vs. maintenance therapy in non-small cell lung cancer.
Velez M, Belalcazar A, Domingo G, Blaya M, Raez LE, and Santos E, Expert Rev Anticancer Ther; 10(4):549-57
Oxaliplatin in Non-Small Cell Lung Cancer.
Raez LE, Kobina S, Santos E, Clin Lung Cancer; 11(1):18-24
Factores asociados a cáncer de pulmón en mujeres.
Farias, Mayra A and Raez, LE, Rev Med Hered
Targeted Therapy in NSCLC.
Alvarez M, Roman E, Santos E, Raez LE, Expert Rev Anticancer Ther; 7(10):1423-37
Primary Hypercoagulable states: Case report and review of the Literature (Spanish).
Raez LE, Chaparro AL, Rev Med Hered; 6 (4): 193-5
Heat Shock Protein-based Cancer Vaccines.
Lee KP, Raez LE, Podack ER, Hematol Oncol Clin North Am; 20(3):637-59
New Developments in Lung Cancer Chemotherapy.
Raez LE,. Lilenbaum R, Curr Opin in Oncol; 18; 156-61
Chemotherapy in Advanced Non-Small Cell Lung Cancer.
Raez LE, Lilenbaum R, Clinical Advances in Hematology/Oncology, 2 (3): 173-177
Primary Central Nervous System Lymphomas in AIDS patients (Review). (Spanish).
Raez LE, Angulo J, Restrepo A, Rev Med Hered; 10 (1)
Prevalence of Post-liver Transplant Lymphoproliferative Disorders (PLTD).
Restrepo A, Albrecht F, Raez LE, Byrne G, Whticomb C, Fernandez H, Cassileth PA, Critical Reviews in Oncogenesis; 10(3):239-246
Mixed Crioglobulinemia and Hepatitis C infection presenting with severe gangrene of the lower limbs (Spanish).
Del Rio M, Raez LE, Rev Med Hered; 8(4): 183-188
Biomodulation of 5-FU in Metastatic colon cancer.
Ardalan B, Raez LE, Merchan J and Franceschi D, Cancer Invest, 16(4): 237-251
Tuberculosis Hepatic Abscess in patients with AIDS (Spanish).
Raez LE, Garcia P, Rev Med Hered; 8 (1): 45-8
Heparin induced thrombocytopenia with thrombosis (HITTS) (Spanish).
Raez LE, Rev Med Hered; 7(3): 132-4
Join now to see all

Books/Book Chapters

Manual de Oncologia Clinica y Molecular.
Chapter: Pancreatic Cancer
Raez LEEOPBA, Buenos Aires, Argentina
Oncology Special Edition 2005.
Chapter: Medical Management of Small Cell Lung Cancer
Raez LE, Lilenbaum RMcMahon Publishing Group, New York
Cancer Vaccines.
Chapter: Lung Cancer Vaccines
Raez LE, Santos E, Mudad RNova Publishers, New York
Lung Cancer in Women.
Blaya M, Santos E, Karr M, Roman E, and Raez LENova Science Editorial Group, New York
Lung Cancer.
Raez LE, Silva OElsevier Science, New York
Tecnologia, Vida, Familia y Etica Medica: Problemas contemporaneous que plantea el avance de la ciencia en el campo medico.
Raez LEInstituto para el Matrimonio y la Familia, Costa Rica
Join now to see all

Abstracts/Posters

Immunotherapy for lung tumors.
Podack, ER; Raez LE, J of Thor Onc 2(8). Supplement 4:S197-S198
Accuracy of endobronchial ultrasound-directed transbronchial needle aspiration (EBUS-TBNA) in mediastinal staging in patients (pts) with non-small cell lung cancer (NS...
Tupayachi MG, Hosein PJ, Nguyen DM, Thurer R, Garcia M, Raez LE, Donna E, J Clin Oncol 28:15s, suppl; abstr 7071
Free circulating DNA by RT-PCR as predictor for chemotherapy response in newly diagnosed patients (pts) with advanced non-small cell lung cancer (NSCLC).
Santos E, Talebi E, Raez LE, Quintero C, Walker G, Farias M, K. Ramachandran, E. Gordian, J. Gomez, R. Singal, J Clin Oncol 28, suppl; abstr e18107
Effectiveness and Tolerance of Maintenance Chemotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.
Santos E, Belalcazar A, Vazquez A, Gomez J, Raez LE, Journal of Thoracic Oncology. 5(5):S97
Using Real Time (RT)-PCR for Glutathione-S-Transferase P1 (GSTP1) gene to measure free circulating DNA in patients with Advanced Non-Small Cell Lung Cancer.
Raez LE, Santos ES, Talebi T, Quintero C, Walker G, Lopez E, Farias M, Singal R, Journal of Thoracic Oncology. 5(5):S45
Pharmacokinetic and Pharmacodynamic Analysis of Patients Treated with the Histone Deacetylase Inhibitor Entinostat in Combination with Erlotinib.
Lee MJ, Adjei A, Bonomi P, Raez LE, Drabkin H, Bodkin D, Trepel J, AACR Molecular Targets and Cancer Therapies Meeting, Boston, MA
A phase II study of cetuximab in combination with chest radiotherapy and consolidation carboplatin and paclitaxel in patients with stage III non-small cell lung cancer...
Kotsakis A, Heron D, Friedland D, Petro D, Tarhini A, Flaugh R, Raez LE, et al, Journal of Thoracic Oncology. 4(9):S786
Racial/ethnic disparities in lung cancer stage of diagnosis and survival.
Raez LE, T. Koru-Sengul, G. Allen, J. Clarke, E. S. Santos, J. J. Hu, J Clin Oncol 27:15s, suppl; abstr 8080
Radiaton pneumonitis with the combination of irinotecan and carboplatin concomitantly with radiation for stage III non-small cell lung cancer.
Raez LE, Hatoum G, Bastos B, Walker G, Tolba K, Farfan N, Karr M, Kobina S, Rodriguez V, Rocha-Lima CM, J Clin Oncol 26: suppl; abstr 7582
Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial.
Feinstein TM, Raez LE, Rajasenan KK, Gibson MK, Savvides P, Karamouzis MV, Garg NV, Johnson R, Branstetter BF, Argiris AE, Clin Oncol 26
Gemcitabine and oxaliplatin (GEMOX), a promissing combination for the treatment of relapsed, advanced or metastatic non small cell lung cancer (NSCLC).
Calfa CJ, Raez LE, Lopes G, Walker G, Farfan N, Macintyre J, Blaya M, M. Rocha-Lima, Clin Oncol 26
Ethnic disparities in head and neck carcinomas (HNC):The Hispanic Paradox.
Escalon M, Calfa C, Farias M, Lopez E, Patel S, Patel V, Raez LE, J Clin Oncol 26
A phase I trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Rocha-Lima CM, Rubin EH, Raez LE, et al, J of Clin Oncol, 2008. ASCO Gastrointestinal Cancer Symposium
Novel tumor vaccine gp96-Ig fusion heat shock protein in advanced non-small cell lung cancer (NSCLC) patients who have failed palliative chemotherapy and erlotinib.
Podack E, Raez LE, E. Fisher, E. Leibovitch, J. E. Gomez, P. Baldie, K. A. Tolba, E. S. Santos, G. Walker, J Clin Oncol 28, suppl; abstr e18042
Gemcitabine and Oxaliplatin as second and third line therapy of advanced and metastatic non-small cell lung cancer (NSCLC): evidence of clinical activity and improvem...
Lopes G; Alencar A; Blaya M; Raez LE; Farfan N; Walker, G; Flores A; MacyntireJ; Rocha-Lima, J of Thor Onc: 2(8) Supplement 4:S683
A Phase II trial of docetaxel, oxaliplatin and bevacizumab as first-line therapy of unresectable, locally advanced or recurrent and/or metastatic (Stage IIIB/IV) non-s...
Raez LE, Babcock W, Sarlis N, Tolba K, Webb T, Brito R, Asbury R, Karr M, Santos E, J of Thor Onc: 2(8) Supplement 4:S735
Responses to the combination of the glycolytic inhibitor 2-deoxy-glucose (2DG) and docetaxel (DC) in patients with lung and head and neck (H/N) carcinomas.
Raez LE, V. Langmuir, K. Tolba, C. M. Rocha-Lima, K. Papadopoulos, S. Kroll, M. Brawer, J. Rosenblatt, A. Ricart, T. Lampidis, J of Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I
Gemcitabine in combination with oxaliplatin as second-line therapy of advanced and metastatic NSCLC.
A. J. Alencar, M. Blaya, Raez LE, N. Farfan, G. Lopes, G. Walker, A. Flores, J. Macintyre, C. Rocha-Lima, J of Clin Oncol, 2007 ASCO Ann Meeting Proceed Part I
Oxaliplatin and capecitabine (XELOX) as first-line therapy for metastatic or relapsed squamous cell carcinoma of the head and neck.
O. E. Silva, K. Tolba, N. Farfan, M. Karr, C. Calfa, Raez LE, J of Clin Oncol, ASCO Ann Meeting Proceed, Part I. Vol 25, No. 18S
Beyond race: The impact of ethnicity on the treatment outcome of locally advanced head and neck cancer.
C. J. Calfa, M. Escalon, S. Zafar, E. Lopez, V. Patel, S. Patel, L. Feun, Raez LE, J of Clin Oncol, ASCO Ann Meeting Proceed, Part I. Vol 25, No. 18S
Re-Irradiation with IMRT and Chemotherapy for Recurrent Head and Neck Cancer.
Roman E; Blaya M; Han HS; Biagioli M; Harvey M; Markoe M; Raez LE, J of Thor Onc; vol 1: 8, 919a
Glycolytic Inhibition with 2-Deoxy-glucose (2-DG) in Patients with Lung and Head and Neck (H/N) Cancers.
Raez LE; Langmuir V; Papadopoulos K; Ricart A; Tolba K; Rocha-Lima C; Schlesselman S; Kroll S; Collowick A; Rosenblatt J; Lampidis T, J of Thor Onc; vol 1: 8, 905a
Consolidation Docetaxel after Concurrent Chemoradiotherapy with Carboplatin and Irinotecan in Unresectable Stage III NSCLC.
Bastos B; Roman E; Negret L; Takita C; Lobo C; Lopes G; Farfan N; Karr M; Rocha-Lima C; Raez LE, J of Thor Onc; vol 1: 8, 902a
Phase II Trial of Fixed Dose Rate (FDR) Gemcitabine (G) in Combination with Oxaliplatin (O) in the 2nd Line Treatment of Patients with Advanced and Metastatic Non-Smal...
Raez LE; Bepler G; Lopes G; Blaya M; Lobo C; Macintyre J; Farfan N; Flores A; Walker G, Rocha-Lima C, J of Thor Onc; vol 1: 8, 901a
Combined Modality Therapy with Carboplatin and Irinotecan followed by Consolidation Docetaxel (CID) for Patients with Stage III Non-small lung cancer (NSCLC).
Roman E, Raez LE, Negret L, Farfan N, Lobo C, Kummar P, Takita C, Karr M, Lopes G, Rocha-Lima C, American Society of Clinical Oncology (ASCO), vol 24
Join now to see all

Lectures

Effect of oligometastatic disease management with stereotactic body radiation therapy on survival in patients with metastatic lung cancer.
2019 ASCO Annual Meeting - 6/1/2019
RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expre...
2019 ASCO Annual Meeting - 6/1/2019
Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC).
2019 ASCO Annual Meeting - 6/1/2019
Clinical responses and survival in Hispanic patients with non-small cell lung cancer treated with immunotherapy compared with non-Hispanic whites.
2019 ASCO Annual Meeting - 6/1/2019
New Developments in Chemotherapy for Head and Neck Cancers.
John F. Kennedy Hospital, Oncology Tumor Board, Boyton Beach-Florida
New Developments in NSCLC Therapy.
II Winter Lung Cancer Conference, Miami
Lung Cancer in Women.
University of Miami, Women’s Cancer Institute
New Developments in Chemotherapy for Lung Cancer.
John F. Kennedy Hospital, Oncology Tumor Board, Boyton Beach-Florida
Targeted Therapy for Non-Small Cell Lung Cancer.
University of Miami Department of Medicine, Medical Grand Rounds
Multimodality Approach to Locally Advance NSCLC.
The 11th Annual Palm Beach Cancer Conference, West Palm Beach-Florida
X Joint Cancer Conferences of the Florida Universities.
West Palm Beach – Florida
Treatment of Small Cell Lung Cancer.
UM/Sylvester Cancer Center Hematology/Oncology Fellowship Program. Miami, Florida
Molecular Markers for Therapy Response in NSCLC.
UM/Sylvester Cancer Center Hematology/Oncology Fellowship Program. Miami, Florida
Update in Lung Cancer Management.
University of Miami Pulmonary Fellows Conference, Miami, Florida
Management of Locally Advanced NSCLC.
The 10th Annual Palm Beach Cancer Conference, West Palm Beach-Florida
Erlotinib in the second line management of patients with NSCLC.
Holy Cross Hospital, Oncology Tumor Board, Fort Lauderdale
Premetrexed as second line chemotherapy for NSCLC.
Memorial Cancer Center Hollywood-Florida, Oncology Tumor Board
Chemotherapy Management of Squamous cell Carcinoma of the Head and Neck.
UM/Sylvester Cancer Center: International Tumor Board
Management of Neutropenia and Neutropenic Fever.
UM/Sylvester Cancer Center Thoracic Oncology Program. Miami
New Developments in Tyrosine kinase Inhibition.
UM/Sylvester Cancer Center Thoracic Oncology Program, Miami, Florida
Roundtable: Case Studies in Lung Cancer Chemotherapy.
UM/Sylvester Cancer Center Hematology/Oncology Fellowship Program, Miami
Challenges in the treatment of chemotherapy induced nausea and comiting.
UM/Sylvester Oncology Nursing Unit, Miami
Angiogenesis in NSLC.
UM/Sylvester Hematology/Oncology Division, Miami, Grand Rounds
Advances in Chemotherapy for NSCLC.
Veterans Affairs Medical Center (VAMC) West Palm Beach: Tumor Board
Chemotherapy in Non-Small Cell Lung Cancer.
University of Miami/Division of Pulmonary Diseases
Join now to see all

Other

Chemotherapy in Advanced Lung Cancer in Understanding Lung Cancer.
Raez LE, Jack Digital Productions (JDP) (CD ROM-Book)
Toronto, Canada

Authored Content

ESMO 2020'S Update on Lung Cancer TreatmentsSeptember 2020

Press Mentions

Navigating the Treatment Landscape for ROS1+ NSCLCOctober 21st, 2024
Advancing the Treatment of ROS1+ NSCLC: An Oncologist’s PerspectiveJuly 24th, 2024
Repotrectinib Expands Treatment Options for Lung Cancers with ROS1 FusionsFebruary 16th, 2024
Join now to see all

Professional Memberships

American College of Chest Physicians - ACCP
Fellow
American College of Physicians - ACP
Fellow

Other Languages

Spanish

External Links

Dr. Luis Raez: Medical Director - Memorial Cancer Institutehttps://www.youtube.com/watch?v=WrhhXZ4i3sk&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=36&t=2s
Dr. Raez on the Role of Liquid Biopsies in Newly Diagnosed Lung Cancerhttps://www.youtube.com/watch?v=I62Klrkau_s&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=1&t=6s
Options for Patients With Lung Cancer and Genetic Alterationshttps://www.youtube.com/watch?v=T0vDmtbD5WI&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=2